跳至主要内容
临床试验/NCT00721890
NCT00721890已完成2 期

Phase II Study: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma

CHU de Quebec-Universite Laval1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2008年6月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
16
试验地点
1
主要终点
time to relapse

研究概览

简要总结

Green tea is extracted from steam treated leaves, allowing the preservation of catechins, the active elements of the infusion. Catechins are recognized for their anti-cancer activity. Catechins act on the capacity of cancer to disseminate to other organs because of their anti-protease action. Proteases are proteins capable of digesting the cancer environment and facilitating the progression of cancer cells to blood vessels which will bring them to distant organs. We know that ovarian cancer responds well to the initial treatment of chemotherapy but tends to recur rapidly. We intend to provide green tea with higher concentrations of catechins to women with complete remission of their ovarian cancer in an attempt to delay cancer relapse. We also intend to identify, with molecular technologies, the proteases involved in ovarian cancer recurrence and response to catechins. Our objective is to test the hypothesis that green tea intake may delay ovarian cancer recurrence and to develop tools to predict which women will best benefit of the addition of green tea to their initial treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •patients with ovarian serous carcinoma FIGO stage III or IV
  • •patients showing complete response after oncological surgery and chemotherapy (paclitaxel-carboplatin, minimum 5 cycles, maximum 8 cycles), complete response being defined as 1) a negative complete physical examination 2) Serum CA-125 levels inferior to 35 U/mL 3) no evidence of diseased assessed by abdomino-perineal CT-scan
  • •patients refraining from drinking tea other than provided by the study
  • •patients who may absorb liquids orally
  • •patients without any other malignancy (except for non-melanoma skin cancer)
  • •patients not involved in an other study
  • •patients who signed up informed consent form.

排除标准

  • •exclusion criteria are implicit from inclusion criteria.

研究组 & 干预措施

1

Experimental

干预措施: Double-Brewed Green Tea (Dietary Supplement)

结局指标

主要结局

time to relapse

时间窗: 36 months

次要结局

  • toxicity(14th and 28th patients recruted and PRN)

研究者

发起方
CHU de Quebec-Universite Laval
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bernard Têtu

Professor, MD

CHU de Quebec-Universite Laval

研究点 (1)

Loading locations...

相似试验

Green Tea Intake for the Maintenance of Complete... | 临床试验